Biotech Banker Predicts More Meetings But Fewer Attendees
Biotech Banker Predicts More Meetings But Fewer Attendees
It’s tougher and tougher for people to figure out what’s the right venue for them, for whatever they’re trying to accomplish…
Biotech Banker Predicts More Meetings But Fewer Attendees
It’s tougher and tougher for people to figure out what’s the right venue for them, for whatever they’re trying to accomplish…
Faulty Genes Explain Why Cloning Is So Difficult
Cloning may not always completely reprogram an egg cell the way sexual reproduction does, which would explain why the process fails so often, researchers reported on Monday.
Two New Bills Present Challenges to DNA Patentability
This time the challenge to the patents, commonly called gene patents, comes from the US House of Representatives in the form of two bills introduced on March 15 by Rep. Lynn Rivers (D-Mich.). If enacted, each of these would threaten future biotech innovation in the US.
Biotech industry’s still waiting to break out
It turns out that even with the genome in hand, discovering drugs and testing them to prove they work is an expensive, grueling process.
Rating the Nation’s Best and Worst Jobs
According to this year’s edition of “Jobs Rated Almanac” the nation’s single best job in terms of low stress, high compensation, lots of autonomy, tremendous hiring demand and several other key criteria, is biologist.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Recent Comments